PP05 Neuroendocrinology

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Neuroendocrinology and Pituitary-Basic
Friday, April 1, 2016: 11:30 AM-11:45 AM
Room 162 (BCEC)
Chairs:
Karine Rizzoti, PhD, The Francis Crick Institute, London, United Kingdom and To Be Determined

Nothing to Disclose: KR Disclosure Not Provided: JDB, MT
Govindan Dayanithi, Department of Molecular Neurophysiology, Institute of Experimental Medicine-AS CR & INSERM 1198-France, Prague, Czech Republic, Stepan Kortus, Departement of Molecular Neurophysiology, Institute of Experimental Medicine-AS CR, Prague, Czech Republic, Oksana Forostyak, Deaprtment of Neuroscience, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, Eva Sykova, Deaprtment of Neuroscience, Institute of Experimental Medicine-AS CR, Prague, Czech Republic and Alexei Verkhratsky, School of Biological Sciences, University of Manchester, Manchester, United Kingdom
Poster Board Number: FRI 476
Gislaine Almeida-Pereira, M.Sc., Ph.D.1, Ricardo Coletti2, Tatiane Vilhena-Franco3, Susana Quirós Cognuck3, Hellen Veiga Silva3, Lucila Elias, M.D., Ph.D.4 and Jose Antunes-Rodrigues, M.D., Ph.D.4, (1)Physiology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil
(2)Universidade de São Paulo, Ribeirão Preto, Brazil
(3)Physiology, School of Medicine of Ribeirao Preto - University of Sao Paulo, Ribeirao Preto, Brazil
(4)Physiology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil
Poster Board Number: FRI 477
Michelle N. Bedenbaugh, Justin A. Lopez, Richard B. McCosh, Robert L. Goodman, Ph.D. and Stanley M. Hileman, Ph.D., Dept. of Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, WV
Poster Board Number: FRI 483

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire